MYBPC3 and advanced heart failure: In contrast, mutations in MYBPC3, the most prevalent genetic cause of hypertrophic cardiomyopathy, exhibit considerable clinical heterogeneity, ranging from asymptomatic carriers to patients with advanced heart failure and sudden cardiac death.